Pathologic myopia: where are we now?.
OBJECTIVE
To describe current concepts and available treatments for pathologic myopia.


METHODS
Review of experimental and clinical studies.


METHODS
The demography, natural history, medical and surgical treatments for choroidal neovascular membrane, vitreoretinal interface disorders and future strategies for pathologic myopia are reviewed.


RESULTS
Several medical and surgical modalities are currently available to treat various complications of pathologic myopia. Macular translocation appears to stabilize or improve visual function in many eyes with choroidal neovascularization.


CONCLUSIONS
Newer strategies are emerging to better ameliorate or prevent the complications of pathologic myopia.
Tano
Yasuo
Y
Department of Ophthalmology, Osaka University, Medical School, Osaka, Japan. tano@ophthal.med.osaka-u.ac.jp
D000818:Animals; D001284:Atrophy; D002829:Choroid / Q000473:pathology; D020256:Choroidal Neovascularization / Q000209:etiology / Q000473:pathology / Q000628:therapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D017075:Laser Coagulation; D008268:Macular Degeneration / Q000209:etiology / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000150:complications* / Q000473:pathology* / Q000628:therapy; D010778:Photochemotherapy; D012160:Retina / Q000473:pathology / Q000637:transplantation; D012167:Retinal Perforations / Q000209:etiology / Q000473:pathology / Q000628:therapy